Armistice Capital, LLC 13D and 13G filings for ProMIS Neurosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 12:28 pm Purchase | 2025-06-30 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 4,812,000 8.580% | 4,812,000 (New Position) | Filing |
| 2025-05-15 3:37 pm Sale | 2025-03-31 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 2,334,826 7.140% | -175,151 (-6.98%) | Filing |
| 2025-02-14 5:17 pm Sale | 2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 2,509,977 7.680% | -160,023 (-5.99%) | Filing |
| 2024-11-14 3:36 pm Purchase | 2024-09-30 | 13G | ProMIS Neurosciences, Inc. PMN | Armistice Capital, LLC | 2,670,000 8.170% | 2,670,000 (New Position) | Filing |